Descending Thoracic Aneurysm TEVAR — EECC MCQ
Instant feedback + full explanation. One question, done properly.
Educational content. Not a substitute for clinical judgement or local policy.
Reveal the answer and explanation
Correct answer: E — TEVAR is recommended for descending thoracic aneurysms ≥55 mm (or growing >5 mm/year) and is particularly advantageous over open repair in patients with significant comorbidities like severe COPD
The ESC 2024 Aortic Disease Guidelines recommend intervention for descending thoracic aortic aneurysms at ≥55 mm (or at smaller sizes if rapid growth >5 mm/year, connective tissue disease, or saccular morphology). TEVAR is the preferred approach for descending thoracic pathology when anatomy is suitable (adequate proximal and distal sealing zones ≥20 mm, suitable access vessels), as it avoids thoracotomy, aortic cross-clamping, and the associated morbidity (paraplegia risk ~3% for TEVAR vs ~5-8% for open repair, lower respiratory complications). This patient with severe COPD (FEV1 35%) would have prohibitive surgical risk for open repair, making TEVAR the clear choice. Long-term surveillance for endoleak is required after TEVAR.
Reference: ESC (2024): Guidelines for Peripheral Arterial and Aortic Diseases